UN
UNH.US UnitedHealth Group Incorporated
- Market cap
- USD 314B
- P/E
- 20.0x
- P/B
- 3.20x
- ROE
- 21.6%
- Dividend yield
- 2.52%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is UNH.US undervalued?
Graham numberUNH.US trades 68.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
UnitedHealth Group Incorporated fundamental analysis
No fundamental analysis for UnitedHealth Group Incorporated yet.
UnitedHealth Group Incorporated stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers softw…
Full company profileUnitedHealth Group Incorporated financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
UnitedHealth Group Incorporated annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 185B | 201B | 226B | 242B | 257B | 288B | 324B | 372B | 400B | 448B | 449B |
| Gross Profit | 43.4B | 47.0B | 53.8B | 57.6B | 67.0B | 69.7B | 79.6B | 91.0B | 89.4B | 82.9B | 112B |
| Operating Income | 12.9B | 15.2B | 17.3B | 19.7B | 22.4B | 24.0B | 28.4B | 32.4B | 32.3B | 19.0B | 31.4B |
| EBITDA | 15.0B | 17.5B | 19.8B | 22.4B | 25.3B | 27.1B | 31.8B | 36.3B | 28.1B | 23.1B | 35.5B |
| Net Income | 7.02B | 10.6B | 12.0B | 13.8B | 15.4B | 17.3B | 20.1B | 22.4B | 14.4B | 12.1B | 21.2B |
| EPS | 7.25 | 11 | 12 | 14 | 16 | 18 | 21 | 24 | 16 | 13 | 23 |
| Balance Sheet | |||||||||||
| Total Assets | 123B | 139B | 152B | 174B | 197B | 212B | 246B | 274B | 298B | 310B | 313B |
| Total Liabilities | 82.3B | 87.0B | 96.0B | 112B | 127B | 136B | 159B | 175B | 196B | 208B | 207B |
| Shareholders' Equity | 38.4B | 49.8B | 51.7B | 57.6B | 65.5B | 71.8B | 77.8B | 88.8B | 92.7B | 94.1B | 98.1B |
| Cash & Short-term Investments | 13.3B | 15.5B | 14.3B | 14.2B | 19.8B | 23.9B | 27.9B | 29.6B | 29.1B | 28.1B | 28.5B |
| Total Debt | 33.0B | 31.7B | 36.6B | 40.7B | 43.5B | 46.0B | 57.6B | 67.4B | 76.9B | 78.4B | 74.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 9.80B | 13.6B | 15.7B | 18.5B | 22.2B | 22.3B | 26.2B | 29.1B | 24.2B | 19.7B | 33.4B |
| Capital Expenditure | 1.71B | 2.02B | 2.06B | 2.07B | 2.05B | 2.45B | 2.80B | 3.39B | 3.50B | 3.62B | 3.23B |
| Free Cash Flow | 8.09B | 11.6B | 13.7B | 16.4B | 20.1B | 19.9B | 23.4B | 25.7B | 20.7B | 16.1B | 30.2B |
| Ratios | |||||||||||
| ROE | 18.3% | 21.2% | 23.2% | 24.0% | 23.5% | 24.1% | 25.9% | 25.2% | 15.5% | 12.8% | 21.6% |
| ROA | 5.7% | 7.6% | 7.9% | 8.0% | 7.8% | 8.1% | 8.2% | 8.2% | 4.8% | 3.9% | 6.8% |
| Net Profit Margin | 3.8% | 5.2% | 5.3% | 5.7% | 6.0% | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% | 4.7% |
| Debt to Equity | 0.86x | 0.64x | 0.71x | 0.71x | 0.66x | 0.64x | 0.74x | 0.76x | 0.83x | 0.83x | 0.76x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
UnitedHealth Group Incorporated dividends
- Dividend yield
- 2.52%
- Forward dividend
- 9.28 USD
- Payout ratio
- 65.7%
- Ex-dividend date
- Dec 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 7.92B | 8.70 | 65.7% |
| 2024 | USD 7.53B | 8.11 | 52.3% |
| 2023 | USD 6.76B | 7.21 | 30.2% |
| 2022 | USD 5.99B | 6.31 | 29.8% |
| 2021 | USD 5.28B | 5.52 | 30.5% |
| 2020 | USD 4.58B | 4.77 | 29.8% |
| 2019 | USD 3.93B | 4.07 | 28.4% |
| 2018 | USD 3.32B | 3.38 | 27.7% |
| 2017 | USD 2.77B | 2.82 | 26.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on May 31, 2005.
Who owns UnitedHealth Group Incorporated
- Insiders 0.27%
- Institutions 89.69%
- Public & others 10.04%
- Shares outstanding 896M
- Free float 893M
Top funds holding UNH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 28.5M | 3.18% | -1.28% | Sep 2026 |
| Vanguard 500 Index Investor | 23.6M | 2.63% | -2.30% | Sep 2026 |
| iShares Core S&P 500 ETF | 12.0M | 1.34% | +0.17% | Oct 2026 |
| Schwab US Dividend Equity ETF | 11.8M | 1.31% | +0.09% | Oct 2026 |
| Fidelity 500 Index | 11.7M | 1.30% | -1.05% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 11.0M | 1.22% | -0.25% | Oct 2026 |
| American Funds Washington Mutual A | 8.60M | 0.96% | -2.86% | Sep 2026 |
| Vanguard MStar Value Index Investor | 8.55M | 0.95% | -1.50% | Sep 2026 |
| American Funds American Balanced A | 7.58M | 0.85% | -8.13% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 6.57M | 0.73% | +0.88% | Oct 2026 |
| American Funds Income Fd of Amer A | 5.27M | 0.59% | -6.28% | Sep 2026 |
| Dodge & Cox Stock I | 5.24M | 0.58% | -12.66% | Sep 2026 |
| State Street®SPDR®DowJonesIndstrAvgETFTr | 5.18M | 0.58% | +0.29% | Oct 2026 |
| Vanguard Dividend Appreciation ETF | 5.08M | 0.57% | -1.21% | Sep 2026 |
| American Funds Fundamental Invs A | 5.01M | 0.56% | +1.91% | Sep 2026 |
| Vanguard Institutional Index I | 4.75M | 0.53% | -2.20% | Sep 2026 |
| Vanguard Health Care Inv | 4.56M | 0.51% | +10.36% | Sep 2026 |
| American Funds Growth Fd of Amer A | 3.92M | 0.44% | -6.49% | Sep 2026 |
| Fidelity Contrafund | 3.85M | 0.43% | +15.04% | Sep 2026 |
Top institutions holding UNH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 76.9M | 8.58% | +4.62% | Jun 2026 |
| Vanguard Capital Management, LLC | 59.3M | 6.62% | +0.75% | Jun 2026 |
| State Street Corp | 45.6M | 5.09% | +0.66% | Jun 2026 |
| Capital World Investors | 29.9M | 3.34% | +7.57% | Jun 2026 |
| FMR Inc | 28.0M | 3.12% | +132.91% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 24.5M | 2.73% | +1.86% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 23.2M | 2.58% | +10.92% | Jun 2026 |
| Geode Capital Management, LLC | 21.8M | 2.43% | -4.47% | Jun 2026 |
| JPMorgan Chase & Co | 20.2M | 2.26% | +5.99% | Jun 2026 |
| Charles Schwab Investment Management Inc | 19.8M | 2.21% | -4.74% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 14.8M | 1.65% | -1.12% | Jun 2026 |
| NORGES BANK | 12.7M | 1.42% | -3.92% | Jun 2026 |
| Bank of New York Mellon Corp | 10.7M | 1.19% | +6.11% | Jun 2026 |
| Wellington Management Company LLP | 10.7M | 1.19% | +5.78% | Jun 2026 |
| Bank of America Corp | 9.74M | 1.09% | -16.88% | Jun 2026 |
| Fisher Asset Management, LLC | 9.08M | 1.01% | +73.40% | Jun 2026 |
| Dodge & Cox | 9.07M | 1.01% | -4.17% | Jun 2026 |
| Northern Trust Corp | 8.76M | 0.98% | -0.21% | Jun 2026 |
| Franklin Templeton Inc | 8.64M | 0.96% | +52.34% | Jun 2026 |
| Capital Research Global Investors | 8.63M | 0.96% | -18.04% | Sep 2026 |
UnitedHealth Group Incorporated company profile
- Company name
- UnitedHealth Group Incorporated
- Ticker
- UNH.US
- Exchange
- USA Stocks
- Listed since
- Oct 26, 1984
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 390,000
- Fiscal year end
- December
- Address
- 1 Health Drive, Eden Prairie, MN, United States, 55344
- Phone
- (800)-328-5979
- Website
- unitedhealthgroup.com
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group Incorporated management
10- Mr. Stephen J. HemsleyCEO & Non-Independent Non-Executive Chairman · born 1953
- Mr. Wayne Scott DeVeydtChief Financial Officer · born 1970
- Mr. Christopher R. ZaettaExecutive VP, Chief Legal Officer & Corporate Secretary · born 1972
- Mr. Timothy John NoelChief Executive Officer of UnitedHealthcare Business · born 1972
- Dr. Patrick Hugh Conway M.D., M.Sc.Chief Executive Officer of Optum · born 1975
- Mr. Dennis StankiewiczChief Accounting Officer & Corporate Controller · born 1978
- Mr. Sandeep DadlaniExecutive VP and Chief Digital & Technology Officer · born 1975
- Ms. Jodeen Ann KozlakChief Administrative Officer · born 1963
- Mr. Zachary William SopcakSenior Vice President of Capital Markets Communications & Investor Relations
- Ms. Erin L. McSweeney J.D.Executive VP & Chief People Officer · born 1965